Sight Diagnostics scoops up $71m Series D
Sight Diagnostics, an Israeli developer of blood analyzers, has raised $71 million in Series D funding.
5 August 2020•1 min read
Sight Diagnostics, an Israeli developer of blood analyzers, has raised $71 million in Series D funding.